Complete Surgical Excision Is the Most Effective Treatment for BI-ALCL
An MD Anderson-led study finds surgery improves survival, reduces recurrence in BI-ALCL.
An MD Anderson-led study finds surgery improves survival, reduces recurrence in BI-ALCL.
Incyte’s sNDA for ruxolitinib cream in children ages 2–11 now faces a new action date to allow additional data review.